Whole-Transcriptome Profiling Reveals RNA Expression Dynamics and ceRNA Network Remodeling across Health, Sepsis, and Sepsis-Associated Acute Respiratory Distress Syndrome

Sepsis is a life-threatening reaction where the body's own defense system turns against itself in response to an infection, causing widespread damage to organs. When this chaotic immune response strikes the lungs, it can lead to a condition called acute respiratory distress syndrome, or ARDS. In this state, the tiny air sacs in the lungs become leaky, filling with fluid and preventing oxygen from reaching the blood. While doctors can diagnose the condition once a patient is struggling to breathe, identifying who is at risk before the lungs fail remains a difficult challenge. The biological shift from a general infection to this specific lung injury involves complex changes in how cells communicate and function, but the exact sequence of these molecular events has remained largely hidden.

To uncover these hidden steps, researchers at the First Affiliated Hospital of Guangxi Medical University decided to look at the complete set of genetic instructions circulating in the blood. They focused on four types of molecules: the standard blueprints for making proteins, known as messenger RNA, and three types of non-coding RNA that act as regulators, managers, or switches for those blueprints. By comparing the blood of healthy people with that of patients who had sepsis but healthy lungs, and then with patients whose sepsis had progressed to lung failure, the team mapped how these genetic signals changed as the disease advanced. They treated the progression from health to severe illness as a continuous journey rather than just comparing separate groups, looking for patterns that rose or fell steadily along the way.

The study involved twelve individuals: four healthy volunteers, four patients with sepsis who had not yet developed lung failure, and four patients whose sepsis had caused acute respiratory distress syndrome. The researchers extracted RNA from blood samples taken from each group and used high-throughput sequencing to read the genetic code. They found that as the condition worsened, the activity of hundreds of genes shifted in a predictable direction. Specifically, they identified 773 genes that changed their expression levels steadily as the disease moved from the healthy state to sepsis and finally to lung failure. Of these, 350 genes became more active, while 423 became less active. These changing genes were heavily involved in the body's immune response, the production of inflammatory signals, and the maintenance of the structural barriers that keep fluids in the blood vessels and out of the air sacs.

Beyond the standard protein-making genes, the researchers also tracked the non-coding regulators. They discovered 189 long non-coding RNAs and 252 circular RNAs that followed the same steady trend of change as the disease progressed. These molecules, which do not code for proteins themselves, appear to be orchestrating the cellular response by managing how other genes are turned on or off. Their activity suggested a disruption in how cells organize their internal structures and how they maintain the tight seals between them. Additionally, six specific microRNAs, which act as fine-tuners of gene expression, showed consistent changes across the three groups. These tiny molecules seemed to be targeting genes responsible for the integrity of cell junctions and the transport of ions, which are critical for keeping the lung's delicate barrier intact.

To understand how these different pieces fit together, the team built a network map showing how these molecules interact. They found that the long non-coding RNAs and circular RNAs often acted as decoys, soaking up the microRNAs to prevent them from silencing their target genes. This created a complex web of regulation centered around a few key microRNAs, including hsa-miR-193b-3p and hsa-miR-223. The genes controlled by this network were linked to the transport of calcium and other ions, the function of cell channels, and the movement of vesicles within the cell. These processes are essential for maintaining the structural integrity of the lung tissue and for the proper signaling between cells during an immune attack.

The findings suggest that the transition from a general infection to severe lung failure is not a sudden event but a gradual remodeling of the body's genetic landscape. The coordinated rise and fall of these coding and non-coding RNAs point to a breakdown in the body's ability to regulate inflammation and maintain the physical barriers of the lung. While the study was limited by a small number of participants and the use of blood samples rather than direct lung tissue, the clear, step-by-step changes observed provide a new map of the molecular journey from health to critical illness. This detailed view of the shifting genetic signals offers potential new targets for understanding the disease and may help in identifying patients who are at risk of developing lung failure before it becomes clinically apparent.